Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRE0094 in diabetic foot ulcers
NCT00318214Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jun 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sonedenoson in diabetic foot ulcer (DFU), sponsored by Pfizer. Started Jun 2006; status: terminated.
02
Drugs
Sonedenoson
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT00318214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318214.